Case Control Study
Copyright ©The Author(s) 2016.
World J Nephrol. Jul 6, 2016; 5(4): 358-366
Published online Jul 6, 2016. doi: 10.5527/wjn.v5.i4.358
Table 3 Univariate and multivariate regression analysis for occurrence of anemia (defined as serum hemoglobin levels < 130 g/L for men and < 120 g/L for women and/or use of recombinant erythropoietin) in the total studied population
ParameterUnivariate analysis
Multivariate analysis
Unadjusted odds ratio (95%CI)PAdjusted odds ratio (95%CI)P
ΒΜΙ Groups
Normal (18.5-25)Reference group
Underweight (< 18.5)0.545 (0.046-6.443)0.63
Overweight (25-30)0.714 (0.377-1.350)0.3
Obese (> 30)0.708 (0.348-1.442)0.342
Age
< 75 yrReference groupReference group
≥ 75 yr1.623 (1.028-2.564)0.0381.198 (0.694-2.069)0.517
Gender
MaleReference groupReference group
Female0.546 (0.357-0.833)0.0050.389 (0.224-0.675)0.001
CKD Stages
Stage 2Reference groupReference group
Stage 3a7.207 (2.656-19.566)< 0.0016.068 (2.112-17.430)0.001
Stage 3b7.162 (2.694-19.038)< 0.0017.499 (2.604-21.597)< 0.001
Stage 411.414 (3.999-32.582)< 0.00112.169 (3.783-39.147)< 0.001
Diabetes1.848 (1.212-2.818)0.0042.206 (1.196-4.069)0.011
Hypertension0.663 (0.280-1.573)0.351
Dyslipidemia0.745 (0.491-1.130)0.1660.659 (0.404-1.074)0.094
Coronary heart disease1.446 (0.934-2.239)0.0981.048 (0.506-1.960)0.883
Heart failure1.725 (1.003-2.967)0.0491.228 (0.628-2.398)0.548
Arrhythmia0.788 (0.412-1.509)0.472
Smoking1.051 (0.662-1.667)0.834
Serum glucose levels (per mg/dL increase)1.006 (1.002 to 1.011)0.0090.999 (0.992-1.005)0.736
Serum iron (per mg/dL increase)0.978 (0.970-0.986)< 0.0010.976 (0.968-0.985)< 0.001
Ferritin (per ng/mL increase)0.998 (0.995-1.001)0.209
24 h urine protein excretion (per mg increase)1.000 (1.000-1.003)0.1461.000 (1.000-1.001)0.772
ACEIs/ARBs0.690 (0.443-1.075)0.1010.963 (0.565-1.641)0.888
Antiplatelet/anticoagulant drugs1.413 (0.927-2.156)0.1081.161 (0.669-2.015)0.595